Intrinsic Edge Capital Management LLC Trans Medics Group, Inc. Transaction History

Intrinsic Edge Capital Management LLC

  • $782 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$53.63 - $82.33 $1.07 Million - $1.65 Million
20,000 New
20,000 $1.51 Million
Q3 2020

Nov 16, 2020
SELL
$13.78 - $18.84 $2.07 Million - $2.83 Million
-150,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$11.66 - $18.26 $1.75 Million - $2.74 Million
150,000 New
150,000 $2.69 Million

Others Institutions Holding TMDX

# of Institutions
395
Shares Held
31.9M
Call Options Held
466K
Put Options Held
286K
View Full List

About TransMedics Group, Inc.

TMDX Quotes by TradingView
  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Intrinsic Edge Capital Management LLC Portfolio

Follow Intrinsic Edge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrinsic Edge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrinsic Edge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email